Lin Wei-Yu, Wu Chun-Te, Chen Miao-Fen, Chang Ying-Hsu, Lin Cheng-Li, Kao Chia-Hung
Division of Urology, Department of Surgery, Chang Gung Memorial Hospital, Chia-Yi, Taiwan.
Nursing Department, Chang Gung University of Science and Technology, Chia-Yi, Taiwan.
Cancer Manag Res. 2018 May 31;10:1413-1418. doi: 10.2147/CMAR.S161566. eCollection 2018.
Radical cystectomy (RC) is an effective but underused treatment for bladder cancer in elderly patients. This study performed analysis of propensity scores (PSs) to determine the outcomes of RC for elderly patients, with results generalizable at the population-based level.
We conducted a population-based, retrospective cohort study of patients who underwent RC in Taiwan during 2000-2010. Multivariable logistic regression was implemented to evaluate 30- and 90-day mortality and readmission rates, length of intensive care unit (ICU) stay, length of hospital stay (LOS), and cost. Enrolled patients were divided into younger (≤75 years) and older groups (>75 years) who were matched according to their PSs.
We identified 430 patients with bladder cancer who underwent RC between 2000 and 2010. Older age was not significantly associated with 30-day readmission (odds ratio [OR] = 0.80, 95% confidence interval [CI] = 0.38-1.70), 90-day readmission (OR = 1.10, 95% CI = 0.60-2.00), 30-day mortality (OR = 3.07, 95% CI = 0.31-30.0), or 90-day mortality (OR = 2.98, 95% CI = 0.91-9.70) in the PS-matched group. Similar trends were also observed for both groups regarding the mean length of ICU stay, LOS, and overall medical expenditure within the same admission.
No significant differences existed between the older and younger groups for 30-and 90-day mortality and readmission rates, length of ICU stay, LOS, and medical expenditure in patients undergoing RC for bladder cancer. Some healthy elderly patients may be good candidates for this extensive curative treatment.
根治性膀胱切除术(RC)是治疗老年膀胱癌患者的一种有效但未得到充分应用的治疗方法。本研究进行倾向评分(PS)分析,以确定老年患者接受RC的治疗结果,其结果可在基于人群的水平上进行推广。
我们对2000年至2010年期间在台湾接受RC的患者进行了一项基于人群的回顾性队列研究。采用多变量逻辑回归来评估30天和90天死亡率、再入院率、重症监护病房(ICU)住院时间、住院时间(LOS)和费用。将入选患者根据PS分为年轻组(≤75岁)和老年组(>75岁),并进行匹配。
我们确定了430例在2000年至2010年期间接受RC的膀胱癌患者。在PS匹配组中,年龄较大与30天再入院(优势比[OR]=0.80,95%置信区间[CI]=0.38-1.70)、90天再入院(OR=1.10,95%CI=0.60-2.00)、30天死亡率(OR=3.07,95%CI=0.31-30.0)或90天死亡率(OR=2.98,95%CI=0.91-9.70)无显著相关性。在同一住院期间,两组在ICU平均住院时间、LOS和总体医疗费用方面也观察到类似趋势。
在接受膀胱癌RC治疗的患者中,老年组和年轻组在30天和90天死亡率、再入院率、ICU住院时间、LOS和医疗费用方面无显著差异。一些健康的老年患者可能是这种广泛根治性治疗的合适人选。